🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
1.500
-0.090 (-5.66%)
At close: Nov 19, 2026, 4:00 PM EST
1.450
-0.050 (-3.33%)
After-hours: Nov 19, 2026, 7:30 PM EST

Elicio Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
421395580--
Market Cap Growth
-72.14%153.09%-31.39%---
Enterprise Value
261345572--
Last Close Price
1.597.965.108.34--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.3985.03-4.867.04--
P/TBV Ratio
2.3985.03-7.04--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.748.87-2.300.610.84-2.88
Net Debt / Equity Ratio
-0.90-2.48-0.74-0.530.15-0.61
Net Debt / EBITDA Ratio
0.440.11-0.190.17-0.06-0.10
Net Debt / FCF Ratio
0.460.11-0.230.18-0.06-0.10
Quick Ratio
3.112.291.531.320.900.49
Current Ratio
3.432.381.801.681.560.55
Return on Equity (ROE)
-315.32%--170157.38%-346.95%-1170.93%-430.76%
Return on Assets (ROA)
-70.58%-87.24%-101.64%-89.70%-79.16%-92.36%
Return on Capital Employed (ROCE)
-129.20%-212.40%-270.10%-205.50%-150.20%626.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-120.11%-28.45%-94.42%-43.93%--
FCF Yield
-82.18%-26.58%-67.60%-40.89%--
Buyback Yield / Dilution
-33.59%-25.48%-141.35%-1500.08%97.93%-42.39%
SEC Filings: 10-K · 10-Q